JP2004525631A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525631A5
JP2004525631A5 JP2002571547A JP2002571547A JP2004525631A5 JP 2004525631 A5 JP2004525631 A5 JP 2004525631A5 JP 2002571547 A JP2002571547 A JP 2002571547A JP 2002571547 A JP2002571547 A JP 2002571547A JP 2004525631 A5 JP2004525631 A5 JP 2004525631A5
Authority
JP
Japan
Prior art keywords
buffer
folding
complexing agent
molecular weight
low molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002571547A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004525631A (ja
Filing date
Publication date
Priority claimed from DE10105912A external-priority patent/DE10105912A1/de
Application filed filed Critical
Publication of JP2004525631A publication Critical patent/JP2004525631A/ja
Publication of JP2004525631A5 publication Critical patent/JP2004525631A5/ja
Pending legal-status Critical Current

Links

JP2002571547A 2001-02-09 2002-02-08 組換えプロテイナーゼk Pending JP2004525631A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10105912A DE10105912A1 (de) 2001-02-09 2001-02-09 Rekombinante Proteinase K
PCT/EP2002/001322 WO2002072634A2 (de) 2001-02-09 2002-02-08 Rekombinante proteinase k

Publications (2)

Publication Number Publication Date
JP2004525631A JP2004525631A (ja) 2004-08-26
JP2004525631A5 true JP2004525631A5 (https=) 2006-12-07

Family

ID=7673417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002571547A Pending JP2004525631A (ja) 2001-02-09 2002-02-08 組換えプロテイナーゼk

Country Status (8)

Country Link
US (1) US20070099283A1 (https=)
EP (1) EP1360284B1 (https=)
JP (1) JP2004525631A (https=)
AT (1) ATE401393T1 (https=)
CA (1) CA2435753A1 (https=)
CZ (1) CZ20032165A3 (https=)
DE (2) DE10105912A1 (https=)
WO (1) WO2002072634A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153666B2 (en) 2003-07-17 2006-12-26 General Atomics Methods and compositions for determination of glycated proteins
ES2404059T3 (es) * 2006-07-25 2013-05-23 General Atomics Procedimientos para analizar el porcentaje de hemoglobina glicada
US7943385B2 (en) 2006-07-25 2011-05-17 General Atomics Methods for assaying percentage of glycated hemoglobin
WO2008063378A2 (en) 2006-11-01 2008-05-29 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
US8148105B2 (en) * 2007-03-16 2012-04-03 The Board Of Trustees Of The Leland Stanford Junior University Scaleable manufacturing process for cysteine endoprotease B, isoform 2
US7682789B2 (en) * 2007-05-04 2010-03-23 Ventana Medical Systems, Inc. Method for quantifying biomolecules conjugated to a nanoparticle
JP2010528285A (ja) 2007-05-23 2010-08-19 ベンタナ・メデイカル・システムズ・インコーポレーテツド 免疫組織化学およびinsituハイブリダーゼーションのためのポリマー担体
EP2283149A1 (en) * 2008-05-13 2011-02-16 General Atomics Electrochemical biosensor for direct determination of percentage of glycated hemoglobin
WO2009149013A2 (en) 2008-06-05 2009-12-10 Ventana Medical Systems, Inc. Compositions comprising nanomaterials and method for using such compositions for histochemical processes
USPP22463P3 (en) * 2010-02-16 2012-01-17 Menachem Bornstein Gypsophila plant named ‘Pearl Blossom’
EP2423217A1 (en) 2010-08-23 2012-02-29 Forschungsverbund Berlin E.V. Peptide and protein affinity tag from mistic protein
CN112592931A (zh) * 2020-12-31 2021-04-02 安徽丰原发酵技术工程研究有限公司 一种生产重组蛋白酶k的方法
CN118165964B (zh) * 2024-04-11 2025-01-24 铭诚惠众(江苏)药物研究有限公司 一种重组蛋白酶k的纯化方法及其应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332805A (en) * 1984-02-03 1994-07-26 Celltech Limited Process for the recovery of recombinantly produced chymosin from insoluble aggregate
US5082775A (en) * 1984-05-11 1992-01-21 Berlex Laboratories, Inc. Efficient process for isolating insoluble heterologous protein using non-ionic detergents
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US5453363A (en) * 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
AU617996B2 (en) * 1987-04-03 1991-12-12 Amgen, Inc. Novel proteolytic enzymes
DE3835350A1 (de) * 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
US5191063A (en) * 1989-05-02 1993-03-02 University Of Medicine And Dentistry Of New Jersey Production of biologically active polypeptides by treatment with an exogenous peptide sequence
US5606031A (en) * 1990-04-06 1997-02-25 Lile; Jack Production and purification of biologically active recombinant neurotrophic protein in bacteria
US5144006A (en) * 1991-06-13 1992-09-01 The Rockefeller University Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides
US5792623A (en) * 1992-04-06 1998-08-11 Immuno Aktiengesellschaft Method for producing activated blood factors with a protease and a detergent
DE4225427A1 (de) * 1992-07-31 1994-02-03 Boehringer Mannheim Gmbh Verfahren zur Gewinnung rekombinanter, biologisch aktiver, eukaryontischer alkalischer Phosphatase
CA2155335C (en) * 1993-02-04 2001-06-05 HANS CHRISTIAN THõGERSEN Improved method for the refolding of proteins
US5747654A (en) * 1993-06-14 1998-05-05 The United States Of America As Represented By The Department Of Health And Human Services Recombinant disulfide-stabilized polypeptide fragments having binding specificity
JPH0748398A (ja) * 1993-08-03 1995-02-21 Nippon Oil Co Ltd 変性蛋白質の再生方法及び変性蛋白質再生剤
US5550262A (en) * 1994-11-14 1996-08-27 Cephalon, Inc. Multicatalytic protease inhibitors
IL117350A0 (en) * 1995-03-09 1996-07-23 Procter & Gamble Proteinase k variants having decreased adsorption and increased hydrolysis
US6342585B1 (en) * 1996-06-11 2002-01-29 Roche Diagnostics Gmbh Method of activating denatured protein
US6426075B1 (en) * 1996-11-06 2002-07-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protease-activatable pseudomonas exotoxin A-like proproteins
US20030207402A1 (en) * 1997-08-22 2003-11-06 Erhard Kopetzki Autocatalytically activatable zymogenic precursors of proteases and their use
WO2000034504A2 (en) * 1998-12-10 2000-06-15 Genetic Vectors, Inc. Method of protein removal
US7351549B2 (en) * 2000-01-24 2008-04-01 Polymun Scientific Immunbiologische Forschung Gmbh Method for the manufacture of recombinant trypsin
US7001724B1 (en) * 2000-11-28 2006-02-21 Applera Corporation Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
MXPA03004835A (es) * 2000-12-15 2005-04-19 Boehringer Ingelheim Ltd Proteasa ns2/3 activa, purificada de virus de hepatitis c.
US7214484B2 (en) * 2002-12-17 2007-05-08 Sigma-Aldrich Co. Compositions and methods for nucleic acid extraction from biological samples

Similar Documents

Publication Publication Date Title
JP2004525631A5 (https=)
Ge et al. Expression and characterization of a histidine-rich protein, Hpn: potential for Ni2+ storage in Helicobacter pylori
TR200202233T2 (tr) Organik iyodürü organik ortamdan ayırma yöntemi.
WO2005012360A3 (en) Binding molecules against sars-coronavirus and uses thereof
EP2767291A3 (en) Treatment of glycogen storage disease type II
JP2007530722A5 (https=)
WO2002058638A3 (en) Serpin drugs for treatment of hiv infection and method of use thereof
NL300896I2 (nl) Neisseira meningitidis serogroep B recombinant gelipideerd fHbp subfamilie B01 eiwit
PT1749029E (pt) Moléculas de ligação capazes de neutralizar o vírus da raiva, e suas utilizações
JP2005536569A5 (https=)
JP2006521826A5 (https=)
JP2002529094A5 (https=)
CY1113391T1 (el) Χρηση ενος συστατικου ενισχυσης διαλυτοτητας σε υδατικη συνθεση που περιλαμβανει τρυγικη βριμονιδινη
TW200700545A (en) Chemical mechanical polishing aqueous dispersion, chemical mechanical polishing method, and kit for preparing chemical mechanical polishing aqueous dispersion
CY1107082T1 (el) Μεθοδος καθαρισμου αλβουμινης η οποια περιλαμβανει ενα σταδιο νανοδιηθησης, διαλυμα και συνθεση για θεραπευτικη χρηση που περιεχουν την ιδια
DE602006004160D1 (de) Niedertemperatur-Trocknungsverfahren zur Herstellung von arzneimittelhaltigen Polymerzusammensetzungen
JP2018500341A5 (https=)
JP2004236637A5 (https=)
DE602004011022D1 (de) Verfahren zur aufreinigung von (hydro)halogenkohlenstoffen
ATE285775T1 (de) Behandlung diabetischer ulcera
EP1796694A4 (en) METHOD FOR IMPROVING HEMODYNAMIC STABILITY WITH OXYGEN-CARRYING COMPOSITIONS
EP1350849A3 (en) Method for cloning and expression of BsaI restriction endonuclease and Bsal methylase in E. coli
ATE299024T1 (de) Purin-2,6-dione als inhibitoren des enzyms dipeptidyl-peptidase iv (dpp-iv)
DK1159426T3 (da) Kloning og udtryk af Haemophilus somnus transferrin-bindende proteiner
JP2006070047A5 (https=)